Editorial Process

This page describes how Living Diabetes researches, writes, reviews, and updates the content on this website. We publish it so readers — and search engines — can see exactly how our information is produced.

Our sources

Every clinical claim on this site is anchored to one or more of the following:

• NICE guidelines and quality standards (UK National Institute for Health and Care Excellence) — including NG17 (type 1), NG18 (children & young people), NG28 (type 2), and NG3 (diabetes in pregnancy)
• NHS public-facing clinical content (nhs.uk)
• The ADA Standards of Care in Diabetes (American Diabetes Association, updated annually)
• Diabetes UK position statements and care recommendations
• Peer-reviewed research indexed on PubMed and the Cochrane Library
• Regulatory updates from the MHRA (UK), EMA, and FDA for medications and devices

Where guidelines disagree (for example, glycaemic targets sometimes differ between NICE and ADA), we say so explicitly and explain the reasoning behind each.

How we write

1. Topic selection. We prioritise questions our readers are actually asking — through search data, support communities, and reader email — alongside topics where current guidance is unclear, conflicting, or recently updated.
2. Evidence review. Before drafting, we summarise what NICE, NHS, ADA, and Diabetes UK currently recommend, and check for any recent randomised trials, systematic reviews, or guideline amendments.
3. Drafting. Articles are written in plain language with the reader’s situation in mind. Numerical thresholds (HbA1c, blood glucose targets, drug dosages) are stated in both UK (mmol/mol, mmol/L) and US (%, mg/dL) units where relevant.
4. Source linking. We link out to the original guideline, paper, or NHS page rather than to other commercial websites, so readers can verify any claim themselves.

How we review

All clinical content is reviewed by qualified registered endocrine clinicians before publication. The reviewer checks that:

• Every clinical statement is supported by current guidance or peer-reviewed evidence
• Drug names, classes, doses, and side-effect profiles are accurate
• Numerical targets and laboratory cut-offs match current standards
• The article is appropriate for a lay readership and avoids prescriptive personal medical advice

The “Last reviewed” date at the foot of every clinical article reflects the most recent review. Articles are re-reviewed at least annually and immediately when major guideline updates are published (for example, the annual ADA Standards of Care or a new NICE update).

How we update

When guidance changes, the affected articles are updated and the “Last reviewed” date is refreshed. Where the change is material — for example, a new first-line therapy or a revised target — we add a brief note at the top of the article summarising what changed and when.

Corrections policy

If you spot an error — clinical, factual, or typographical — please email editorial@livingdiabetes.com. We respond to every correction request, and where the error is material we update the article and add a dated correction note.

What we don’t do

• We don’t sell anything to readers. Living Diabetes does not sell supplements, devices, programmes, or memberships, and we do not provide personalised medical consultations.
• We don’t accept paid placement. No company, brand, or product can buy a position in our content. Where a specific drug or device is named, it is because it is clinically relevant to the topic.
• We don’t reproduce press releases. Industry announcements are reported only after we have read the underlying trial data or regulatory submission.
• We don’t replace your healthcare team. Our content is educational. Your decisions about diet, medication, and self-management should always involve your GP, diabetes specialist nurse, dietitian, or endocrinologist.

Funding and ownership

Living Diabetes is editorially independent. Operating costs are covered by display advertising and, where relevant, affiliate links to non-medical products such as cookbooks. Affiliate income does not influence which products we mention or how we describe them.

Last updated: May 2026.